CSIMarket
 


Pmv Pharmaceuticals Inc   (PMVP)
Other Ticker:  
 

Cumulative Pmv Pharmaceuticals Inc 's Quick Ratio for Trailing Twelve Months Period

PMVP's Quick Ratio for Trailing Twelve Months Period and Cash & cash equivalent, Current Liabilities growth


Select the Comparisons : Select the Ratio:

PMVP Quick Ratio for Trailing Twelve Months Period

(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
Y / Y Current Liabilities Growth 36.12 % 51.69 % 101.6 % 90.62 % 56.37 %
Y / Y Cash & cash equivalent Growth -15.86 % -12.85 % -14.63 % -17.78 % -17.55 %
Quick Ratio for Trailing Twelve Months Period 23.78 26.57 30.18 36.81 46.65
Total Ranking # 76 # 106 # 91 # 73 # 39
Seq. Current Liabilities Growth 2.4 % -2.58 % -4.37 % 42.7 % 14.11 %
Seq. Cash & cash equivalent Growth -6.7 % -1.96 % -4.77 % -3.41 % -3.36 %


Quick Ratio for Trailing Twelve Months Period Comment
On the trailing twelve months basis Due to rise in Current Liabilities in the III. Quarter to $12 millions, average cumulative Quick Ratio for Trailing Twelve Months Period decreased to 23.78 below Pmv Pharmaceuticals Inc average Quick Ratio for Trailing Twelve Months Period.
Quick Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies operatig within Major Pharmaceutical Preparations industry 28 other companies have achieved higher Quick Ratio for Trailing Twelve Months Period than Pmv Pharmaceuticals Inc . While Quick Ratio for Trailing Twelve Months Period overall ranking has improved so far to 76, from total ranking in previous quarter at 106.

What is Quick Ratio?
Learn more about PMVP
Quick Ratio PMVP in the most recent quarter
Quick Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 29
Sector # 42
S&P 500 # 76


Quick Ratio for Trailing Twelve Months Period Statistics
High Average Low
59.25 39.74 23.78
(Mar 31 2021)   (Sep 30 2022)




Companies with similar average Quick Ratio for Trailing Twelve Months Period for 12 months ending Sep 30 2022, within Major Pharmaceutical Preparations Industry Quick Ratio for Trailing Twelve Months Period
Altimmune inc   62.53 
Aptinyx Inc   60.65 
Tyra Biosciences Inc   59.67 
Turning Point Therapeutics Inc.  56.51 
Lexaria Bioscience Corp   56.44 
Essa Pharma inc   52.38 
Design Therapeutics Inc   51.82 
Aerovate Therapeutics Inc.  49.38 
Xbiotech Inc   48.19 
Atossa Therapeutics Inc   45.35 
Nuvation Bio Inc   44.80 
Annovis Bio inc   43.24 
Xenon Pharmaceuticals Inc   39.46 
Terns Pharmaceuticals Inc   38.89 
Anebulo Pharmaceuticals Inc  37.99 
Zomedica Corp   37.11 
Infinity Pharmaceuticals Inc   34.80 
Theseus Pharmaceuticals inc   34.51 
Cocrystal Pharma Inc.  33.51 
Artelo Biosciences Inc   32.95 
Eqrx Inc   31.28 
Stoke Therapeutics Inc   30.70 
Rezolute Inc   30.10 
Nanoviricides inc   29.85 
Day One Biopharmaceuticals Inc   29.51 
Immix Biopharma Inc   29.01 
Nuvalent Inc   28.15 
Synaptogenix Inc   27.97 
Diamedica Therapeutics Inc   27.74 
Kezar Life Sciences Inc   27.63 


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

FCCN's Profile

Stock Price

FCCN's Financials

Business Description

Fundamentals

Charts & Quotes

FCCN's News

Suppliers

FCCN's Competitors

Customers & Markets

Economic Indicators

FCCN's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071